Clinical trials sponsored by Henan Cancer Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Henan Cancer Hospital

• A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
  NCT04547907 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy
  NCT07559786 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer
  NCT07540533 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer
  NCT05911958 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
  NCT05377658 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
  NCT05918328 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: Female · 1 location
• Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
  NCT06276868 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study
  NCT07037576 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001
  NCT07264569 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis
  NCT06643000 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat Transplantation
  NCT07037537 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung Cancer
  NCT07559097 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
  NCT05596344 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.
  NCT06781281 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer
  NCT06967103 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal Cancer
  NCT06293014 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Henan Cancer Hospital recruiting for?

Henan Cancer Hospital is the lead sponsor of 16 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.